In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Nicola Maurea
Speaker
Nicola Maurea
Nicola Maurea Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

Speciality : Acute Heart Failure

12 presentations from this speaker

Cardioprotection in cancer patients - Treating the high risk patient.

Event : ESC Congress 2019

  • Session : Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
  • Speaker : N Maurea (Naples,IT)

Cardiotoxicity induced by the combinatorial treatment based on the immune checkpoint inhibitor pembrolizumab associated to trastuzumab

Event : ESC Congress 2019

  • Session : Risk Factors and Prevention, Cardiovascular Disease in Special Populations
  • Speaker : N Maurea (Naples,IT)

Cardiovascular toxicity of targeted cancer therapies.

Event : ESC Congress 2018

  • Session : Cardio-oncology: emerging concepts, challenges and clinical opportunities
  • Speaker : N Maurea (Naples,IT)
  • Joint with the American Heart Association

Cardiotoxic effects of the novel anti-ErbB2 agent Ado trastuzumab emtansine

Event : Heart Failure 2017

  • Session : Basic science - Translational biomarkers and cardio-renal syndrome
  • Speaker : N Maurea (Naples,IT)

Ranolazine partially blunts ado trastuzumab emtansine related cardiotoxicity

Event : Heart Failure 2017

  • Session : Basic science - Translational biomarkers and cardio-renal syndrome
  • Speaker : N Maurea (Naples,IT)

Ranolazine protects from trastuzumab cardiomyopathy

Event : Heart Failure 2016

  • Session : Basic Science: Co-morbidities
  • Speaker : N Maurea (Naples,IT)

Cardioprotection induced by ranolazine after trastuzumab treatment: the reduction of cardiotoxicity in vitro and in vivo study

Event : ESC Congress 2015

  • Session : Cardiotoxicity of antineoplaste drugs, diagnosis and treatments
  • Speaker : N Maurea (Naples,IT)

Ranolazine at the end of Trastuzumab therapy prevents left ventricular dysfunction

Event : Heart Failure 2015

  • Session : Moderated Poster Session 5 - Basic mechanisms in heart failure
  • Speaker : N Maurea (Naples,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are